Dr. Reddy's Laboratories Files Routine 6-K Report
Ticker: RDY · Form: 6-K · Filed: Nov 27, 2024 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, 6-k, reporting
TL;DR
DRL filed a 6-K, just routine paperwork.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on November 27, 2024, to report information as a foreign private issuer. The filing does not contain specific financial figures or material events beyond its routine reporting nature.
Why It Matters
This filing indicates Dr. Reddy's Laboratories is fulfilling its regular reporting obligations as a foreign private issuer with the SEC, which is standard practice for publicly traded international companies.
Risk Assessment
Risk Level: low — This filing is a standard procedural report and does not contain new material information that would typically impact stock price or indicate significant risk.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001575872-24-001211 (filing_id) — Accession Number
- 20241127 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. It is used to furnish information which the issuer makes or is required to make public pursuant to the laws of its home country, or which is made or is required to be made public by, or filed with, a stock exchange on which the issuer has securities listed.
Who is the filer of this document?
The filer is DR REDDYS LABORATORIES LTD.
What is the SEC file number for Dr. Reddy's Laboratories?
The SEC file number for Dr. Reddy's Laboratories is 001-15182.
When was this Form 6-K filed?
This Form 6-K was filed on November 27, 2024.
Does this filing indicate any new financial results or material events?
Based on the provided text, this Form 6-K appears to be a routine filing and does not explicitly detail new financial results or specific material events.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-11-27 08:39:08
Filing Documents
- drr0700_6k.htm (6-K) — 14KB
- drr0700_ex99-1.htm (EX-99.1) — 11KB
- drr0700_ex99-1img01.jpg (GRAPHIC) — 4KB
- drr0700_ex99-1img02.jpg (GRAPHIC) — 17KB
- 0001575872-24-001211.txt ( ) — 55KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: November 27, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3